Ludwig Knabl

824 total citations
21 papers, 254 citations indexed

About

Ludwig Knabl is a scholar working on Infectious Diseases, Immunology and Molecular Biology. According to data from OpenAlex, Ludwig Knabl has authored 21 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 7 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Ludwig Knabl's work include SARS-CoV-2 and COVID-19 Research (16 papers), COVID-19 Clinical Research Studies (11 papers) and Long-Term Effects of COVID-19 (4 papers). Ludwig Knabl is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (16 papers), COVID-19 Clinical Research Studies (11 papers) and Long-Term Effects of COVID-19 (4 papers). Ludwig Knabl collaborates with scholars based in Austria, United States and United Kingdom. Ludwig Knabl's co-authors include Priscilla A. Furth, Lothar Hennighausen, Hye‐Kyung Lee, Dorotheé von Laer, Janine Kimpel, Annika Rössler, Wegene Borena, Mary Walter, Barbara Falkensammer and Samuel Wilks and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Ludwig Knabl

18 papers receiving 249 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ludwig Knabl Austria 10 206 54 54 30 29 21 254
John S. Burke United States 6 258 1.3× 37 0.7× 76 1.4× 55 1.8× 32 1.1× 9 301
David Hillus Germany 4 282 1.4× 47 0.9× 39 0.7× 25 0.8× 33 1.1× 8 300
Alex Richter United Kingdom 6 278 1.3× 59 1.1× 29 0.5× 14 0.5× 18 0.6× 9 327
Garrick K. Yip Hong Kong 3 270 1.3× 50 0.9× 40 0.7× 30 1.0× 38 1.3× 4 307
Jia Xin Yee Singapore 4 140 0.7× 42 0.8× 47 0.9× 20 0.7× 21 0.7× 9 169
Rachael E. Whaley United States 2 198 1.0× 56 1.0× 44 0.8× 17 0.6× 24 0.8× 2 214
Ashley Otter United Kingdom 8 207 1.0× 29 0.5× 48 0.9× 36 1.2× 28 1.0× 21 277
Chengzi I. Kaku United States 7 230 1.1× 52 1.0× 93 1.7× 29 1.0× 38 1.3× 9 276
Elli Rosenberg Israel 8 159 0.8× 46 0.9× 38 0.7× 21 0.7× 32 1.1× 17 248
Marshall Lammers United States 3 166 0.8× 50 0.9× 61 1.1× 25 0.8× 10 0.3× 5 202

Countries citing papers authored by Ludwig Knabl

Since Specialization
Citations

This map shows the geographic impact of Ludwig Knabl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ludwig Knabl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ludwig Knabl more than expected).

Fields of papers citing papers by Ludwig Knabl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ludwig Knabl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ludwig Knabl. The network helps show where Ludwig Knabl may publish in the future.

Co-authorship network of co-authors of Ludwig Knabl

This figure shows the co-authorship network connecting the top 25 collaborators of Ludwig Knabl. A scholar is included among the top collaborators of Ludwig Knabl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ludwig Knabl. Ludwig Knabl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hennighausen, Lothar, Sung‐Gwon Lee, Jungwook Kim, et al.. (2025). Impact of rare JAK/STAT germline mutations on vaccination-induced innate immune responses in a Tyrolian population. International Journal of Biological Sciences. 22(2). 519–528.
2.
Hennighausen, Lothar, T. Haikarainen, Sung‐Gwon Lee, et al.. (2025). Investigation of the transcriptional impact of rare germline JAK/STAT variants found in a Tyrolean alpine community. BMC Genomics. 27(1). 8–8.
3.
Rössler, Annika, Antonia Netzl, Ludwig Knabl, et al.. (2024). Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera. npj Vaccines. 9(1). 85–85. 3 indexed citations
4.
Hoffmann, Markus, Hye‐Kyung Lee, Ludwig Knabl, et al.. (2024). Blood transcriptomics analysis offers insights into variant-specific immune response to SARS-CoV-2. Scientific Reports. 14(1). 2808–2808. 4 indexed citations
5.
Eichhorn, Tanja, René Weiss, Silke Huber, et al.. (2023). Expression of Tissue Factor and Platelet/Leukocyte Markers on Extracellular Vesicles Reflect Platelet–Leukocyte Interaction in Severe COVID-19. International Journal of Molecular Sciences. 24(23). 16886–16886. 5 indexed citations
6.
Knabl, Ludwig, et al.. (2023). High prevalence group testing in epidemiology with geometrically inspired algorithms. Scientific Reports. 13(1). 18910–18910. 1 indexed citations
7.
Rössler, Annika, Antonia Netzl, Ludwig Knabl, et al.. (2023). Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography. Nature Communications. 14(1). 5224–5224. 18 indexed citations
8.
Rössler, Annika, Ludwig Knabl, Antonia Netzl, et al.. (2023). Durability of Cross-Neutralizing Antibodies 5.5 Months After Bivalent Coronavirus Disease 2019 Vaccine Booster. The Journal of Infectious Diseases. 229(3). 644–647.
9.
Lee, Hye‐Kyung, Ludwig Knabl, Mary Walter, Priscilla A. Furth, & Lothar Hennighausen. (2022). Limited cross-variant immune response from SARS-CoV-2 Omicron BA.2 in naïve but not previously infected outpatients. iScience. 25(11). 105369–105369. 8 indexed citations
10.
Lee, Hye‐Kyung, Ludwig Knabl, Mary Walter, et al.. (2022). Prior Vaccination Exceeds Prior Infection in Eliciting Innate and Humoral Immune Responses in Omicron Infected Outpatients. Frontiers in Immunology. 13. 916686–916686. 20 indexed citations
11.
Knabl, Ludwig, Hye‐Kyung Lee, August Zabernigg, et al.. (2022). BNT162b2 vaccination enhances interferon-JAK-STAT-regulated antiviral programs in COVID-19 patients infected with the SARS-CoV-2 Beta variant. SHILAP Revista de lepidopterología. 2(1). 20 indexed citations
12.
Lee, Hye‐Kyung, Ludwig Knabl, Juan I. Moliva, et al.. (2022). mRNA vaccination in octogenarians 15 and 20 months after recovery from COVID-19 elicits robust immune and antibody responses that include Omicron. Cell Reports. 39(2). 110680–110680. 20 indexed citations
13.
Lee, Hye‐Kyung, Heungsup Sung, Seong Who Kim, et al.. (2022). Heterologous ChAdOx1-BNT162b2 vaccination in Korean cohort induces robust immune and antibody responses that includes Omicron. iScience. 25(6). 104473–104473. 21 indexed citations
14.
15.
Rössler, Annika, Antonia Netzl, Ludwig Knabl, et al.. (2022). BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants. Nature Communications. 13(1). 7701–7701. 42 indexed citations
16.
Huber, Silke, et al.. (2021). Systemic Inflammation and Complement Activation Parameters Predict Clinical Outcome of Severe SARS-CoV-2 Infections. Viruses. 13(12). 2376–2376. 17 indexed citations
17.
Borena, Wegene, Zoltán Bánki, Katie Bates, et al.. (2021). Persistence of immunity to SARS-CoV-2 over time in the ski resort Ischgl. EBioMedicine. 70. 103534–103534. 12 indexed citations
18.
Knabl, Ludwig, Tanmay Mitra, Janine Kimpel, et al.. (2021). High SARS-CoV-2 seroprevalence in children and adults in the Austrian ski resort of Ischgl. Communications Medicine. 1(1). 4–4. 38 indexed citations
19.
Lehmann, Jens, Johannes M. Giesinger, Gerhard Rumpold, et al.. (2021). Estimating seroprevalence of SARS-CoV-2 antibodies using three self-reported symptoms: development of a prediction model based on data from Ischgl, Austria. Epidemiology and Infection. 149. e52–e52. 2 indexed citations
20.
Lee, Hye‐Kyung, Ludwig Knabl, André Volland, et al.. (2021). Immune transcriptomes of highly exposed SARS-CoV-2 asymptomatic seropositive versus seronegative individuals from the Ischgl community. Scientific Reports. 11(1). 4243–4243. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John S. Burke Breakdown of academic impact, for papers by David Hillus Breakdown of academic impact, for papers by Alex Richter Breakdown of academic impact, for papers by Garrick K. Yip Breakdown of academic impact, for papers by Jia Xin Yee Breakdown of academic impact, for papers by Rachael E. Whaley Breakdown of academic impact, for papers by Ashley Otter Breakdown of academic impact, for papers by Chengzi I. Kaku Breakdown of academic impact, for papers by Elli Rosenberg Breakdown of academic impact, for papers by Marshall Lammers
Rankless by CCL
2026